Global transmission of oseltamivir-resistant influenza - PubMed (original) (raw)

. 2009 Mar 5;360(10):953-6.

doi: 10.1056/NEJMp0900648. Epub 2009 Mar 2.

Affiliations

• PMID: 19258250
• DOI: 10.1056/NEJMp0900648

Free article

Global transmission of oseltamivir-resistant influenza

Anne Moscona. N Engl J Med. 2009.

Free article

No abstract available

PubMed Disclaimer

Similar articles

• Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.
  Baz M, Abed Y, Papenburg J, Bouhy X, Hamelin ME, Boivin G. Baz M, et al. N Engl J Med. 2009 Dec 3;361(23):2296-7. doi: 10.1056/NEJMc0910060. Epub 2009 Nov 11. N Engl J Med. 2009. PMID: 19907034 No abstract available.
• Oseltamivir resistance: what does it mean clinically?
  Baum SG. Baum SG. Clin Infect Dis. 2009 Dec 15;49(12):1836-7. doi: 10.1086/648425. Clin Infect Dis. 2009. PMID: 19911972 No abstract available.
• Drug resistance. A 'wimpy' flu strain mysteriously turns scary.
  Enserink M. Enserink M. Science. 2009 Feb 27;323(5918):1162-3. doi: 10.1126/science.323.5918.1162. Science. 2009. PMID: 19251605 No abstract available.
• Influenza virus susceptibility and resistance to oseltamivir.
  Aoki FY, Boivin G, Roberts N. Aoki FY, et al. Antivir Ther. 2007;12(4 Pt B):603-16. Antivir Ther. 2007. PMID: 17944268 Review.
• Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
  Ikematsu H, Kawai N. Ikematsu H, et al. Expert Rev Anti Infect Ther. 2011 Oct;9(10):851-7. doi: 10.1586/eri.11.112. Expert Rev Anti Infect Ther. 2011. PMID: 21973296 Review.

Cited by

• Quantitative Proteomics Analysis of Systemic Responses and Biological Mechanisms of ShuFengJieDu Capsule Using H1N1-Infected RAW264.7 Cells.
  Tao Z, Chen J, Su J, Wu S, Yuang Y, Yao H, Wong CCL, Lu H. Tao Z, et al. ACS Omega. 2020 Jun 18;5(25):15417-15423. doi: 10.1021/acsomega.0c01545. eCollection 2020 Jun 30. ACS Omega. 2020. PMID: 32637816 Free PMC article.
• Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium.
  Burnham AJ, Armstrong J, Lowen AC, Webster RG, Govorkova EA. Burnham AJ, et al. J Virol. 2015 Apr;89(8):4575-87. doi: 10.1128/JVI.02473-14. Epub 2015 Feb 11. J Virol. 2015. PMID: 25673705 Free PMC article.
• Molecular Characterization of Seasonal Influenza A and B from Hospitalized Patients in Thailand in 2018-2019.
  Boonnak K, Mansanguan C, Schuerch D, Boonyuen U, Lerdsamran H, Jiamsomboon K, Sae Wang F, Huntrup A, Prasertsopon J, Kosoltanapiwat N, Puthavathana P. Boonnak K, et al. Viruses. 2021 May 25;13(6):977. doi: 10.3390/v13060977. Viruses. 2021. PMID: 34070388 Free PMC article.
• An intranasal nanoparticle STING agonist protects against respiratory viruses in animal models.
  Leekha A, Saeedi A, Kumar M, Sefat KMSR, Martinez-Paniagua M, Meng H, Fathi M, Kulkarni R, Reichel K, Biswas S, Tsitoura D, Liu X, Cooper LJN, Sands CM, Das VE, Sebastian M, Hurst BL, Varadarajan N. Leekha A, et al. Nat Commun. 2024 Jul 18;15(1):6053. doi: 10.1038/s41467-024-50234-y. Nat Commun. 2024. PMID: 39025863 Free PMC article.
• Permissive secondary mutations enable the evolution of influenza oseltamivir resistance.
  Bloom JD, Gong LI, Baltimore D. Bloom JD, et al. Science. 2010 Jun 4;328(5983):1272-5. doi: 10.1126/science.1187816. Science. 2010. PMID: 20522774 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information